Showing results (931-940 of 1,105) with videos related to

Sort By:
Pageof 111
Proceedings of the National Academy of Sciences of the United States of America|May 3, 2000
Single-molecule protein folding: diffusion fluorescence resonance energy transfer studies of the denaturation of chymotrypsin inhibitor 2A A Deniz, T A Laurence, G S Beligere, et al.
Journal of Virology|December 28, 2002
Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytesStefan F Wieland, Raquel G Vega, Rolf Müller, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2008
Protein evolution with an expanded genetic codeChang C Liu, Antha V Mack, Meng-Lin Tsao, et al.
G3 (Bethesda, Md.)|March 4, 2016
The Genetic Basis of Baculum Size and Shape Variation in MiceNicholas G Schultz, Jesse Ingels, Andrew Hillhouse, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2001
Functionalized xenon as a biosensorM M Spence, S M Rubin, I E Dimitrov, et al.
Chemistry & Biology|April 26, 2011
Small molecule antagonists in distinct binding modes inhibit drug-resistant mutant of smoothenedHaiyan Tao, Qihui Jin, Dong-In Koo, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 11, 2010
Identification of RING finger protein 4 (RNF4) as a modulator of DNA demethylation through a functional genomics screenXiaoyi V Hu, Tânia M A Rodrigues, Haiyan Tao, et al.
Cancer Treatment Reviews|February 17, 2022
Immunotherapy versus chemotherapy as first-line treatment for advanced urothelial cancer: A systematic review and meta-analysisAlberto Martini, Daniele Raggi, Giuseppe Fallara, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 10, 2009
Site-directed spin labeling of a genetically encoded unnatural amino acidMark R Fleissner, Eric M Brustad, Tamás Kálai, et al.
Current Medical Research and Opinion|May 28, 2026
Quantifying US healthcare provider preferences for the treatment of post-transplant cytomegalovirus infection using a discrete choice experimentZoe Raglow, Dan Kaul, Ana María Rodriguez, et al.
Pageof 111